Evommune is a startup based in the United States, most recent round Series A, 3 tracked investors.
Based in the United States, Evommune is a startup. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
Evommune is a clinical-stage biotechnology company developing novel small molecule and biologic therapies. Their focus is on treating inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.